SIRT1-FOXO1 Signaling in Cancer

Area of Science:

• Molecular Biology
• Cancer Biology
• Epigenetics

Background:

• Sirtuin 1 (Sirt1) is an NAD+-dependent deacetylase regulating gene transcription and cellular functions.
• Forkhead box protein O1 (FOXO1) is a key transcription factor and substrate of Sirt1, controlling diverse cellular processes.
• The Sirt1-FOXO1 signaling pathway plays a complex role in cancer, with context-dependent effects on tumorigenesis and progression.

Purpose of the Study:

• To explore the intricate mechanisms of Sirt1-FOXO1 signaling in cancer pathophysiology.
• To investigate the pathway's role in tumorigenesis, cancer progression, and drug resistance.
• To discuss current in vitro and in vivo data to identify new research directions and therapeutic strategies.

Main Methods:

• Review and synthesis of existing in vitro and in vivo experimental data.
• In-depth discussion of molecular mechanisms governing Sirt1-FOXO1 pathway activation in cancer.
• Analysis of the pathway's dual role in promoting or inhibiting cancer development and treatment response.

Main Results:

• The Sirt1-FOXO1 pathway exhibits context-specific roles in cancer, influencing tumorigenesis, progression, and drug resistance.
• Various molecular mechanisms modulate this pathway, leading to contradictory outcomes across different cancer types and models.
• The pathway's activation can either promote or inhibit tumor growth and malignancy.

Conclusions:

• Understanding the complex Sirt1-FOXO1 signaling is crucial for deciphering cancer pathophysiology.
• Further investigation is needed to elucidate the pathway's precise roles and harness it for therapeutic development.
• This perspective highlights potential new research avenues for targeted cancer therapies.